{"id":"https://openalex.org/W2560545968","doi":"https://doi.org/10.1182/blood.v128.22.4768.4768","title":"Undertreatment of Patients (Pts) with Myelodysplastic Syndromes (MDS): Analysis of a Large Electronic Medical Records (EMR) Database Cohort of US Pts with MDS","display_name":"Undertreatment of Patients (Pts) with Myelodysplastic Syndromes (MDS): Analysis of a Large Electronic Medical Records (EMR) Database Cohort of US Pts with MDS","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2560545968","doi":"https://doi.org/10.1182/blood.v128.22.4768.4768","mag":"2560545968"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.4768.4768","doi":"https://doi.org/10.1182/blood.v128.22.4768.4768","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.4768.4768","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090527595","display_name":"David P. Steensma","orcid":"https://orcid.org/0000-0001-5130-9284","observed_orcids":["https://orcid.org/0000-0001-5130-9284"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Steensma","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart L Scott","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center & U. of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center & U. of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090259653","display_name":"Xiaomei Ma","orcid":"https://orcid.org/0000-0001-9472-8032","observed_orcids":["https://orcid.org/0000-0001-9472-8032"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaomei Ma","raw_affiliation_strings":["Yale University School of Public Health, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Public Health, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016830534","display_name":"Albert Fliss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert Fliss","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025352490","display_name":"Pavel Kiselev","orcid":"https://orcid.org/0000-0002-6456-6412","observed_orcids":["https://orcid.org/0000-0002-6456-6412"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pavel Kiselev","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083089947","display_name":"Arlene S. Swern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arlene S. Swern","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108484967","display_name":"Mary M. Sugrue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary M. Sugrue","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6336,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.76982598,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"128","issue":"22","first_page":"4768","last_page":"4768"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/undertreatment","display_name":"undertreatment","score":0.9959999918937683},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9480000138282776},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9860000014305115},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/iron-chelation-therapy","display_name":"iron chelation therapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.546999990940094},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.33000001311302185},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.36899998784065247},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8379521369934082},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.749627947807312},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.6922016143798828},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.6148428320884705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5594574213027954},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.543203592300415},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5156491994857788},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.44880396127700806},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.41078466176986694},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3386409878730774},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.18860504031181335},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.4768.4768","doi":"https://doi.org/10.1182/blood.v128.22.4768.4768","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.4768.4768","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2883085566","https://openalex.org/W2889122331","https://openalex.org/W4385655050","https://openalex.org/W2411430750","https://openalex.org/W4317567651","https://openalex.org/W2605284819","https://openalex.org/W2557462780","https://openalex.org/W3016477368","https://openalex.org/W2537994188","https://openalex.org/W4385654967"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Little":[2],"is":[3],"known":[4],"about":[5],"current":[6],"care":[7],"patterns":[8],"for":[9,66,152,196,242,268,385,683,712,717],"pts":[10,31,67,159,208,263,310,342,375,416,435,442,511,519,535,578,587,590,621,630,699],"with":[11,16,68,72,122,173,257,294,326,344,467,643,654,700],"MDS":[12,30,644,701,716],"across":[13],"the":[14,19,36,75,145,192,202,239,266,312,315,323,646,671,677,688,696,713],"US":[15],"respect":[17],"to":[18,80,139,252,650],"use":[20],"of":[21,28,64,82,119,187,206,218,226,245,249,254,262,289,301,341,365,377,405,412,455,485,537,553,632,679,704,715,747],"available":[22],"therapeutic":[23],"agents.":[24],"Using":[25],"a":[26,120,243,298,338,381,409,418,458,483,680],"cohort":[27],"5,162":[29,158],"we":[32,53],"previously":[33,530],"identified":[34],"from":[35,77,656],"GE":[37],"Centricity":[38],"EMR":[39,76,146,240],"database":[40],"(GE":[41],"Healthcare":[42],"IT,":[43],"Princeton,":[44],"NJ)":[45],"(Ma":[46],"X,":[47],"et":[48,662],"al.":[49,663],"Blood.":[50],"2015;126:abstract":[51],"3319),":[52],"examined":[54],"associations":[55],"between":[56],"pt":[57],"characteristics":[58,149,195],"and":[59,107,260,274,331,370,429,493,497,504,564,570,588,595,617,694,706],"treatment":[60,94,154,186,197,316,400,714],"patterns,":[61],"including":[62],"sequence":[63,121,484],"therapies":[65,486,675],"MDS.":[69,684],"Methods:":[70],"Pts":[71,90,181,236,292,394,469,607,641],"data":[73,134],"in":[74,87,114,129,142,191,201,238,265,482,489,577,604,645,722],"Jan":[78],"2006":[79],"end":[81],"Feb":[83],"2014":[84],"were":[85,91,126,135,150,209,229,237,311,368,464,487,574],"included":[86,128],"this":[88,130,723],"analysis.":[89],"grouped":[92],"by":[93,215,692],"received":[95,163,169,183,306,348,380,396,444,450,471,513,525,531,541,548,556,580,591,623,635],"(erythropoiesis-stimulating":[96],"agents":[97,102],"[ESA],":[98],"lenalidomide":[99],"[LEN],":[100],"hypomethylating":[101],"[HMA;":[103],"azacitidine":[104],"or":[105,116,354,477,749],"decitabine],":[106],"iron":[108],"chelation":[109],"therapy":[110,282,382,449,529,560,690,698],"[ICT]),":[111],"either":[112],"alone,":[113],"combination,":[115],"as":[117,132,211,231,360,398,438,446,515,527,543,558,582,593,625,637],"part":[118],"other":[123],"therapies.":[124,180],"Transfusions":[125],"not":[127],"analysis,":[131],"transfusion":[133],"often":[136,695],"unrecorded":[137],"due":[138],"transfusions":[140],"occurring":[141],"facilities":[143],"outside":[144],"system.":[147],"Pt":[148],"evaluated":[151],"each":[153,605],"group.":[155,606],"Results:":[156],"Of":[157,533],"evaluated,":[160],"1,843":[161],"(35.7%)":[162],"only":[164,174,697],"1":[165,171,185,234,272],"therapy,":[166,172,545],"2,079":[167],"(40.3%)":[168],"\u2265":[170,178,184,233],"236":[175],"(4.6%)":[176],"receiving":[177,232,436,608],"2":[179,275],"who":[182,395,443,470,512,524,540,555,579,622],"interest":[188],"are":[189,199,648,670,686],"shown":[190,200],"Figure.":[193],"Baseline":[194],"groups":[198,317],"Table.":[203],"A":[204],"total":[205],"85":[207],"recorded":[210,230],"having":[212],"deletion":[213],"5q":[214],"International":[216],"Classification":[217],"Diseases,":[219],"Ninth":[220],"Revision,":[221],"Clinical":[222],"Modification":[223],"(ICD-9-CM)":[224],"coding;":[225],"these,":[227],"66":[228],"treatment.":[235,393,440],"system":[241,267],"median":[244,299,363,410,420,424,431,551,565,568,571,599,613],"29":[246],"days":[247],"(date":[248],"first":[250,296,346,399,439,448,516,544,559,583,626,638,689],"entry":[251],"date":[253],"last":[255],"entry),":[256],"36%,":[258],"26%,":[259],"15%":[261],"present":[264],">":[269],"6":[270],"months,":[271],"year,":[273],"years,":[276,372,495,563,719],"respectively.":[277,373],"The":[278],"most":[279,332,672],"common":[280],"initial":[281],"was":[283,561,601],"ESA":[284,295,307,345,437,581],"(n":[285,350,356,401,461,474,479,520],"=":[286,351,357,402,462,475,480,521],"1,508;":[287],"72.5%":[288],"treated":[290,293,343,378,406,456,466,538,633],"pts).":[291],"had":[297,322,334,408,417,498,611],"age":[300,319,411,490,552,600],"78.0":[302],"years;":[303],"1,330":[304],"(88%)":[305],"exclusively.":[308],"ESA-only":[309],"oldest":[313],"among":[314],"(median":[318,491],"79.0":[320],"years),":[321],"highest":[324],"proportion":[325,340],"comorbidities":[327],"at":[328,508],"baseline":[329,509],"(69%),":[330],"commonly":[333,673],"isolated":[335],"anemia.":[336],"Only":[337,628],"small":[339,459],"subsequently":[347,465],"LEN":[349,397,445,472,514,526,705],"79;":[352,522],"5.2%)":[353],"HMA":[355,388,542,549,592,609,624],"68;":[358],"4.5%)":[359],"second":[361,473,528,594],"therapy;":[362],"ages":[364],"these":[366],"patients":[367,554],"76.0":[369,492],"73.5":[371],"682":[374],"(32.7%":[376],"pts)":[379,407,539,634],"approved":[383,711],"specifically":[384],"MDS,":[386],"i.e.":[387],"and/or":[389],"LEN,":[390],"during":[391],"their":[392,447],"258;":[403],"12.4%":[404],"74.0":[413,494],"years.":[414],"These":[415],"lower":[419,423,575],"hemoglobin":[421],"(Hb),":[422],"absolute":[425],"neutrophil":[426],"count":[427,433,573,619],"(ANC),":[428],"similar":[430,488,499],"platelet":[432,506,572,618],"vs":[434],"Most":[441,518],"it":[451],"exclusively":[452],"(244;":[453],"94.6%":[454],"pts);":[457],"number":[460],"14)":[463],"HMAs.":[468],"99)":[476],"third":[478,596,610],"13)":[481],"respectively)":[496],"Hb":[500,566,614],"levels,":[501],"higher":[502,505,612],"ANCs,":[503],"counts":[507],"than":[510,576,620],"therapy.":[517,584,627,639],"80%)":[523],"ESA.":[532],"252":[534],"(12.1%":[536],"228":[546],"(90.4%)":[547],"only;":[550],"HMAs":[557],"75.0":[562],"level,":[567,615],"ANC,":[569,616],"Another":[585],"100":[586],"28":[589],"therapies,":[597],"respectively;":[598],"73.0":[602],"years":[603],"61":[629],"(2.9%":[631],"ICT":[636],"Conclusions:":[640],"diagnosed":[642],"USA":[647],"likely":[649],"be":[651],"undertreated.":[652],"Consistent":[653],"findings":[655],"physician":[657],"surveys":[658],"(e.g.":[659],"Sekeres":[660],"M.,":[661],"J":[664],"Natl":[665],"Cancer":[666],"Inst.":[667],"2008;100:1542-51),":[668],"ESAs":[669,685],"used":[674],"despite":[676],"lack":[678],"labeled":[681],"indication":[682],"usually":[687],"chosen":[691],"physicians":[693],"receive.":[702],"Use":[703],"HMA,":[707],"which":[708],"have":[709],"been":[710],"~10":[718],"appears":[720],"low":[721],"EMR.":[724],"Disclosures":[725],"Steensma:":[726],"Genoptix:":[727],"Consultancy;":[728,730,732,737],"Celgene:":[729],"Millenium/Takeda:":[731],"Ariad:":[733],"Equity":[734,758,763,767,772],"Ownership;":[735],"Amgen:":[736],"Janssen:":[738],"Consultancy.":[739,754],"Scott:Celgene:":[740],"Consultancy,":[741],"Membership":[742],"on":[743],"an":[744],"entity's":[745],"Board":[746],"Directors":[748],"advisory":[750],"committees.":[751],"Ma:Celgene":[752],"Corporation:":[753,756,761,770],"Fliss:Celgene":[755],"Employment,":[757,762,766,771],"Ownership.":[759,764,768,773],"Kiselev:Celgene":[760],"Swern:Celgene:":[765],"Sugrue:Celgene":[769]},"counts_by_year":[{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-12-16T00:00:00"}